Cell Culture Market worth $24,574 million by 2018

The report “Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018”, the global cell culture market was valued at an estimated $14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018.

Browse 91 market data tables and 19 figures spread through 209 Pages and in-depth TOC on "Cell Culture Market"

Early buyers will receive 10% customization on this report.


The cell culture market is segmented on the basis of cell culture equipment and cell culture media, sera, and reagents. Each of these two market segments is further divided into multiple product segments and subsegments. The cell culture equipment market consists of five segments, namely, bio-safety cabinets, consumables, lab equipment, sterilization equipment, and storage equipment. Of these, the lab equipment product segment had the largest share of the cell culture equipment market in 2013, whereas the consumables product segment is expected to grow at the highest CAGR between 2013 and 2018. The subsegments of the lab equipment segment are cell counters, centrifuges fermentors & bioreactors, and incubators. The subsegments of the storage equipment segments are cryogenic storage and refrigerators and freezers.


Get The PDF Brochure For This Report:


The cell culture media, sera, and reagents market consists of six segments, namely, contamination detection kits, cryoprotective agents, lab reagents, media, serum, and other reagents. Of these, the serum product segment had the largest share of the cell culture media, sera, and reagents market in 2013, whereas the media product segment is expected to grow at the highest CAGR between 2013 and 2018. The subsegments of the lab reagents segment are balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The subsegments of the media segment are basal media, reduced serum media, and serum-free media.


The application segments included in this report are biopharmaceutical production, cancer research, drug screening and development, gene therapy, tissue culture and engineering, toxicity testing, vaccine production, and other applications. The biopharmaceutical production application segment had the largest share of the cell culture equipment market in 2013, whereas the vaccine production application segment is expected to grow at the highest CAGR between 2013 and 2018. The geographic segments included in this report are North America, Europe, Asia-Pacific, and Rest of the World.


Get The Sample Copy Of This Report:


Biopharmaceuticals are pharmaceutical products isolated from living systems like cells. As such, cell culture is the most widely used technique for biopharmaceutical production. Increasing demand for biopharmaceuticals will be the most important growth driver for the cell culture market. Furthermore, strong product pipelines for vaccine and antibodies, increasing healthcare expenditure, and increasing adoption of single-use technologies will aid the growth of this market.


The major players in the cell culture market include Becton, Dickinson and Company (U.S.), Corning (U.S.), Eppendorf (Germany), General Electric (U.S.), Lonza (Switzerland), Merck (Germany), Promocell (Germany), Sartorius (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific (U.S.).


Browse Related Reports:

Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018.


Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018


About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.


M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.


We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Subscribe Reports from Healthcare Domain @


Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @